Leidos Holdings, Inc.: Form 10-Q for the period ended Apr 2, 2021
Filed with the SEC on May 4, 2021 and accepted by EDGAR at May 4, 2021, 13:20 ET.
Management's discussion and analysis
As filed, 20,610 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of Leidos Holdings, Inc.'s ("Leidos") financial condition, results of operations, and quantitative and qualitative discussion about business environment and trends should be read in conjunction with Leidos' condensed consolidated financial statements and related notes.
The following discussion contains forward-looking statements, including statements regarding our intent, belief or current expectations with respect to, among other things, trends affecting our financial condition or results of operations, backlog, our industry, the impact of our merger and acquisition activity, government budgets and spending, our business contingency plans and our ability to recover certain costs through the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"). Such statements are not guarantees of future performance and involve risks and uncertainties, including uncertainties relating to the coronavirus pandemic ("COVID-19") and the actions taken by authorities and us to respond, and actual results may differ materially from those in the forward-looking statements as a result of various factors. Some of these factors include, but are not limited to, the risk factors set forth in our Annual Report on Form 10-K, as updated by the risk factor in this report under Part II, Item 1A. "Risk Factors" and as may be further updated in subsequent filings with the U.S. Securities and Exchange Commission. Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to update these factors or to publicly announce the results of any changes to our forward-looking statements due to future events or developments.
Unless indicated otherwise, references in this report to "we," "us" and "our" refer collectively to Leidos and its consolidated subsidiaries.
Overview
We are a FORTUNE 500® science, engineering and information technology company that provides services and solutions in the defense, intelligence, civil and health markets, both domestically and internationally. We bring domain-specific capability and cross-market innovations to customers in each of these markets by leveraging five technical core competencies: digital modernization, cyber operations, mission software systems, integrated systems and mission operations. Our customers include the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Veterans Affairs and many other U.S. civilian, state and local government agencies as well as foreign government agencies. We operate in three reportable segments: Defense Solutions, Civil and Health. Additionally, we separately present the unallocable costs associated with corporate functions as Corporate.
COVID-19
For the three months ended April 2, 2021, COVID-19 did not have a material impact to revenues and operating income. The full extent of the impact of the COVID-19 pandemic on our operational and financial performance, including our ability to execute on programs in the expected timeframe, will depend on future developments, including the duration and spread of the pandemic and the distribution of vaccines, all of which are uncertain and cannot be predicted. While we have been able to make some recoveries, the ultimate timing and amount of recoveries remain uncertain as they will depend on a range of government actions, including each government agency and/or contracting officer's implementation of the authority granted in Section 3610 of the CARES Act, a $2 trillion coronavirus response bill providing widespread emergency relief, including the availability of funds. As a result of Congress passing government fiscal year ("GFY") 2021 appropriations, the relief from the CARES Act has been extended until September 30, 2021.
Business Environment and Trends
U.S. Government Markets
During the three months ended April 2, 2021, we generated approximately 87% of our total revenues from contracts with the U.S. government. Accordingly, our business performance is affected by the overall level of U.S. government spending, especially on national security, homeland security and intelligence, and the alignment of our service and product offerings and capabilities with current and future budget priorities of the U.S. government.
On April 9, 2021, the President submitted the GFY 2022 discretionary funding request to Congress.The submission provided spending levels for defense and non-defense federal agencies.The Administration plans to release the full President’s Budget in May of 2021, providing additional details of the discretionary requests and non-discretionary spending. The GFY 2022 funding request follows the passage of the $1.9 trillion American Rescue Plan Act of 2021 in March and the proposed $2.25 trillion American Jobs Plan.
International Markets
Sales to customers in international markets represented approximately 9% of total revenues for the three months ended April 2, 2021. Our international customers include foreign governments and their agencies. Our international business increases our exposure to international markets and the associated international regulatory and geopolitical risks.
Changes in international trade policies, including higher tariffs on imported goods and materials, may increase our procurement costs of certain IT hardware used both on our contracts and for internal use. However, we expect to recover certain portions of these higher tariffs through our cost-plus contracts. While we evaluate the impact of higher tariffs, currently, we do not expect tariffs to have a significant impact to our business.
Results of Operations
The following table summarizes our condensed consolidated results of operations for the periods presented:
(dollars in millions)
| Three Months Ended April 2, 2021 | April 3, 2020 | Dollar change | Percent change | |
|---|---|---|---|---|
| Revenues | $3,315 | $2,889 | $426 | 14.7% |
| Operating income | 308 | 192 | 116 | 60.4% |
| Non-operating expense, net | (46) | (62) | 16 | (25.8)% |
| Income before income taxes | 262 | 130 | 132 | 101.5% |
| Income tax expense | (57) | (15) | (42) | NM |
| Net income attributable to Leidos common stockholders | $205 | $115 | $90 | 78.3% |
| Operating margin | 9.3% | 6.6% |
NM - Not Meaningful
Segment and Corporate Results
(dollars in millions)
| Defense Solutions | Three Months Ended April 2, 2021 | April 3, 2020 | Dollar change | Percent change |
|---|---|---|---|---|
| Revenues | $1,958 | $1,705 | $253 | 14.8% |
| Operating income | 152 | 95 | 57 | 60.0% |
| Operating margin | 7.8% | 5.6% |
The increase in revenues for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to program wins, a net increase in volumes on certain programs and a $24 million benefit in exchange rate movements. The acquisition of Dynetics contributed incremental revenues of $83 million in the current quarter, which represents an additional month of revenues as compared to the prior year quarter and our acquisition of the 1901 Group contributed $13 million of revenues. The increases in revenues were partially offset by the completion of certain contracts.
The increase in operating income for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily due to program wins, a net increase in volumes on certain higher margin programs and lower indirect expenditures. This was partially offset by the completion of certain contracts.
(dollars in millions)
| Civil | Three Months Ended April 2, 2021 | April 3, 2020 | Dollar change | Percent change |
|---|---|---|---|---|
| Revenues | $766 | $654 | $112 | 17.1% |
| Operating income | 74 | 59 | 15 | 25.4% |
| Operating margin | 9.7% | 9.0% |
24
The increase in revenues for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to $72 million of revenues related to the acquisition of L3Harris Technologies' security detection and automation business (the "SD&A Businesses") in the second quarter of fiscal 2020 and a net increase in program volumes.
The increase in operating income for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to a $26 million net benefit from an adjustment to legal reserves related to the Mission Support Alliance joint venture, partially offset by $8 million of increased amortization related to intangible assets from the acquisition of the SD&A Businesses.
(dollars in millions)
| Health | Three Months Ended April 2, 2021 | April 3, 2020 | Dollar change | Percent change |
|---|---|---|---|---|
| Revenues | $591 | $530 | $61 | 11.5% |
| Operating income | 102 | 73 | 29 | 39.7% |
| Operating margin | 17.3% | 13.8% |
The increase in revenues for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to a net increase in volumes on certain programs and program wins, partially offset by the completion of certain contracts.
The increase in operating income for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to a net increase in higher margin program volumes.
(dollars in millions)
| Corporate | Three Months Ended April 2, 2021 | April 3, 2020 | Dollar change | Percent change |
|---|---|---|---|---|
| Operating loss | (20) | (35) | 15 | (42.9)% |
The decrease in operating loss for the three months ended April 2, 2021, as compared to the three months ended April 3, 2020, was primarily attributable to a net decrease in acquisition and integration costs and a decrease in litigation costs.
Non-Operating Expense, net
Non-operating expense, net for the three months ended April 2, 2021 was $46 million as compared to $62 million for the three months ended April 3, 2020. The change was primarily due to $19 million of debt discount and debt issuance costs written off during the prior year quarter related to the refinancing of our term loans.
Provision for Income Taxes
For the three months ended April 2, 2021, our effective tax rate was 21.8% compared to 11.5% for the three months ended April 3, 2020. The increase in the effective tax rate was primarily due to a decrease in benefits related to employee stock-based payments and a prior period release of a valuation allowance related to foreign tax credits.
Bookings and Backlog
We recorded net bookings worth an estimated $3.8 billion during the three months ended April 2, 2021, as compared to $5.5 billion for the three months ended April 3, 2020.
The estimated value of our total backlog was as follows:
(in millions)
| Defense Solutions: | April 2, 2021 | January 1, 2021 |
|---|---|---|
| Funded backlog | $4,142 | $3,710 |
| Negotiated unfunded backlog | 14,393 | 14,721 |
| Total Defense Solutions backlog | $18,535 | $18,431 |
| Civil: | ||
| Funded backlog | $1,531 | $1,398 |
| Negotiated unfunded backlog | 6,857 | 7,051 |
| Total Civil backlog | $8,388 | $8,449 |
| Health: | ||
| Funded backlog | $1,310 | $1,486 |
| Negotiated unfunded backlog | 4,348 | 3,546 |
| Total Health backlog | $5,658 | $5,032 |
| Total: | ||
| Funded backlog | $6,983 | $6,594 |
| Negotiated unfunded backlog | 25,598 | 25,318 |
| Total backlog | $32,581 | $31,912 |
The change in backlog for the Defense Solutions reportable segment reflects $115 million of backlog acquired as a result of the acquisition of 1901 Group.
Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts, both funded and unfunded. Backlog does not include unexercised option periods and future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ") contracts, General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded and separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future anticipated task orders. Total backlog at April 2, 2021 included a benefit of $20 million when compared to total backlog at January 1, 2021, due to exchange rate movements in the British pound and Australian dollar when compared to the U.S. dollar. Backlog estimates are subject to change and may be affected by factors including modifications of contracts and foreign currency movements.
Liquidity and Capital Resources
Overview
As of April 2, 2021, we had $377 million in cash and cash equivalents. Additionally, we have an unsecured revolving credit facility which can provide up to $750 million in additional borrowing, if required. As of April 2, 2021, there were no borrowings outstanding under the credit facility and we were in compliance with the related financial covenants.
At April 2, 2021, and January 1, 2021, we had outstanding debt of $4.8 billion and $4.7 billion, respectively.
We made principal payments on our long-term debt of $26 million and $2 million during the three months ended April 2, 2021 and April 3, 2020, respectively. This activity included required principal payments on our term loans of $24 million during the three months ended April 2, 2021. The senior unsecured term loans and notes contain financial covenants and customary restrictive covenants. We were in compliance with all covenants as of April 2, 2021.
We paid dividends of $50 million and $51 million during the three months ended April 2, 2021 and April 3, 2020, respectively.
During the three months ended April 2, 2021 and April 3, 2020, we sold $465 million and $564 million, respectively, of accounts receivable under accounts receivable purchase agreements and received proceeds of $464 million and $563 million, respectively (see "Note 9–Sale of Accounts Receivable").
Stock repurchases of Leidos common stock may be made on the open market or in privately negotiated transactions with third parties including through accelerated share repurchase ("ASR") agreements. Whether repurchases are made and the timing and actual number of shares repurchased depends on a variety of factors including price, corporate capital requirements, other market conditions and regulatory requirements. The repurchase program may be accelerated, suspended, delayed or discontinued at any time.
During the three months ended April 2, 2021, we made open market repurchases of our common stock for an aggregate purchase price of $100 million.
COVID-19 has negatively impacted the financial markets and may impact our liquidity; we will continue to assess our liquidity needs as the pandemic evolves.
For the next 12 months, we anticipate that we will be able to meet our liquidity needs, including servicing our debt, through cash generated from operations, available cash balances, sales of accounts receivable and, if needed, borrowings under our revolving credit facility.
Summary of Cash Flows
The following table summarizes cash flow information for the periods presented:
(in millions)
| Three Months Ended April 2, 2021 | April 3, 2020 | |
|---|---|---|
| Net cash provided by operating activities | $239 | $372 |
| Net cash used in investing activities | (244) | (1,685) |
| Net cash (used in) provided by financing activities | (148) | 1,161 |
| Net decrease in cash, cash equivalents and restricted cash | $(153) | $(152) |
Net cash provided by operating activities decreased $133 million for the three months ended April 2, 2021, when compared to the prior year quarter. The decrease was primarily due to the lower customer advance payments, lower sale of accounts receivable and the timing of vendor payments.
Net cash used in investing activities decreased $1,441 million for the three months ended April 2, 2021, when compared to the prior year quarter, primarily due to $214 million of net cash paid related to the acquisition of 1901 Group compared to $1,642 million of net cash paid related to the acquisition of Dynetics in the prior year quarter.
Net cash used in financing activities increased $1,309 million for the three months ended April 2, 2021, when compared to the prior year quarter, primarily due to $1,250 million of proceeds received related to the issuance of the Bridge Facility in the prior year quarter, open market stock repurchases of $100 million and the timing of quarterly principal payments, partially offset by $38 million of capital contributions to Hanford Mission Integration Solutions from non-controlling interests.
Off-Balance Sheet Arrangements
We have outstanding performance guarantees and cross-indemnity agreements in connection with certain aspects of our business. We also have letters of credit outstanding principally related to performance guarantees on contracts and surety bonds outstanding principally related to performance and subcontractor payment bonds as described in "Note 11–Commitments and Contingencies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q. These arrangements have not had, and management does not believe it is likely that they will in the future have, a material effect on our liquidity, capital resources, operations or financial condition.
Guarantor and Issuer of Guaranteed Securities
Leidos Holdings, Inc.has fully and unconditionally guaranteed the obligations of its subsidiary, Leidos, Inc. under its $500 million notes due May 2023, $500 million notes due May 2025, $750 million due May 2030 and $1,000 million notes due February 2031 (collectively, "the Notes"). The underlying subsidiaries of Leidos, Inc do not guarantee these obligations and have been excluded from the financial information presented below.
We have entered into registration rights agreements, pursuant to which we agreed to use reasonable best efforts to file registration statements to permit the exchange of the Notes and related guarantees for registered notes having terms substantially identical thereto, or in the alternative, the registered resale of the Notes and related guarantees under certain circumstances.
Summarized financial information for Leidos Holdings, Inc. and Leidos, Inc., net of eliminations, for the year ended April 2, 2021 was as follows (in millions):
Balance Sheet
| Total current assets | $1,774 |
| Goodwill | 4,142 |
| Investments in consolidated subsidiaries | 4,503 |
| Other long-term assets | 1,435 |
| Total assets | $11,854 |
| Total current liabilities | $2,086 |
| Long-term debt, net of current portion | 4,661 |
| Intercompany payables | 1,174 |
| Other long-term liabilities | 834 |
| Total liabilities | 8,755 |
| Total equity | 3,099 |
| Total liabilities and stockholders' equity | $11,854 |
Income Statement
| Revenues, net | $2,220 |
| Operating income | 197 |
| Net income attributable to Leidos common stockholders | 96 |
Contractual Obligations and Commitments
We are subject to a number of reviews, investigations, claims, lawsuits, other uncertainties and future obligations related to our business. For a discussion of these items, see "Note 11–Commitments and Contingencies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.
Critical Accounting Policies
There were no material changes to our critical accounting policies, estimates or judgments during the period covered by this report from those discussed in our Annual Report on Form 10-K for the year ended January 1, 2021 except for the elimination of the Income Taxes critical accounting policy.
Recently Adopted and Issued Accounting Standards
For a discussion of these items, see "Note 1–Basis of Presentation and Summary of Significant Accounting Policies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.
Market risk
As filed, 149 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes in our market risk exposure from those discussed in our Annual Report on Form 10-K for the year ended January 1, 2021.
Controls and procedures
As filed, 2,248 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer (our Chairman and Chief Executive Officer) and principal financial officer (our Executive Vice President and Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of April 2, 2021. Based upon that evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. These disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
On January 14, 2021 and May 4, 2020, we completed the acquisitions of 1901 Group and the SD&A Businesses, respectively. In conducting our evaluation of the effectiveness of our internal control over financial reporting, we excluded 1901 Group and the SD&A Businesses from our evaluation for the first quarter of fiscal 2021. We are in the process of integrating 1901 Group and the SD&A Businesses into our system of internal control over financial reporting. As of April 2, 2021, we completed the integration of Dynetics into our controls over financial reporting.
Other than the foregoing, there have been no changes in our internal control over financial reporting that occurred in the quarterly period covered by this report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes to the risks described in Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended January 1, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-04-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-02 to 2021-04-02 | $3.29bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-01-02 to 2021-04-02 | $2.85bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2021-01-02 to 2021-04-02 | $159.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-01-02 to 2021-04-02 | $308.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-01-02 to 2021-04-02 | $57.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-02 to 2021-04-02 | $205.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-02 to 2021-04-02 | $1.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-02 to 2021-04-02 | $1.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-02 to 2021-04-02 | 144,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-01-02 to 2021-04-02 | $239.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-02 to 2021-04-02 | $26.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2021-01-02 to 2021-04-02 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-04-02 | $377.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-04-02 | $3.26bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-04-02 | $12.64bn | us-gaap:Assets |
| Current liabilities | At period end2021-04-02 | $2.92bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-04-02 | $8.66bn | us-gaap:Liabilities |
| Current portion of debt | At period end2021-04-02 | $103.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2021-04-02 | $3.93bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001336920-21-000019. Last ingested by Listed: Nov 3, 2026, 11:59 ET. Listed shows no prices and gives no investment advice.